Riyadh: Precision medicine represents a qualitative leap in the treatment of rare genetic diseases, as diagnoses now rely on genetic structure rather than visible symptoms, in a transformation led by biotechnology. The scientific field harnesses living organisms and their molecular features to enhance human health, quality of life, and resource sustainability.
According to Saudi Press Agency, biotechnology is not a scientific luxury, but a cornerstone of health sovereignty and pharmaceutical security. For this reason, the Kingdom has placed biotechnology among its strategic priorities. On January 25, 2024, His Royal Highness Prince Mohammed bin Salman bin Abdulaziz Al Saud, Crown Prince and Prime Minister, launched the National Biotechnology Strategy as a comprehensive roadmap to transform the Kingdom into a global hub in this vital sector by 2040.
The Kingdom's participation in BIO International Convention 2025, the world's largest biotechnology event, held in Boston, featured a fully integrated Saudi pavilion led by the Ministry of Health and included the participation of 25 entities. This unified national representation of Saudi Arabia's biotechnology ecosystem marks a new phase in the Kingdom's global presence as an emerging and influential hub in the field, in line with the goals of Saudi Vision 2030 and the National Biotechnology Strategy.
Saudi investment in biotechnology reflects a comprehensive human-centered health vision. These advanced technologies enable precise disease diagnosis and the development of personalized treatments based on each person's genetic profile, paving the way for a new era in personalized medicine. The National Biotechnology Strategy focuses on four strategic directions: localizing vaccine production, biopharmaceutical manufacturing, genomic research and gene therapy, and agricultural biotechnology enhancement. Each area has a tangible impact on human health, the national economy, and life sustainability.
Concerning employment and talent empowerment, the National Biotechnology Strategy underscores the Kingdom's commitment to developing national human capital. The strategy aims to create over 11,000 quality jobs by 2030, rising to 55,000 by 2040. The approach aligns with Saudi Vision 2030, which seeks to diversify the economy, localize vital sectors, and empower national talent to take on advanced, specialized roles, contributing to a knowledge- and innovation-based economy and enhancing the Kingdom's regional and global competitiveness.